Herbal Medicine and Metabolic Syndrome: Phytochemicals Targeting the Molecular Causes of Insulin Resistance and Related Comorbidities

Metabolic Syndrome (MetS) is a global health concern characterized by a cluster of interrelated metabolic abnormalities, including insulin resistance, central obesity, dyslipidemia, hypertension, and chronic low-grade inflammation. These factors significantly increase the risk of developing Type 2 Diabetes Mellitus (T2DM), Cardiovascular Disease (CVD), and other complications. In recent years, plant-derived natural products and herbal medicines have garnered increasing attention for their potential to modulate the underlying mechanisms of Metabolic Syndrome (MetS) safely and cost-effectively. This review explores the therapeutic role and molecular mechanisms of several key botanicals, including berberine, <i>Cinnamomum cassia</i> (Cinnamon), <i>Zingiber officinale</i> (ginger), <i>Trigonella foenum-graecum</i> (Fenugreek), <i>Nigella sativa</i> (black seed), <i>Curcuma longa</i> (Curcumin), <i>Artemisia dracunculus</i> (Russian tarragon), <i>Momordica charantia</i> (bitter melon), and <i>Vaccinium angustifolium</i> (lowbush blueberry). These agents exert multifaceted effects, including the activation of AMPK, enhancement of insulin receptor signaling, increased GLUT4 translocation, anti-inflammatory and antioxidant activities, and modulation of lipid metabolism and gut microbiota. While preclinical data strongly support their efficacy, human clinical trials have shown mixed results due to factors such as inconsistent formulations, poor bioavailability, and individual variability. Despite these challenges, the evidence suggests that plant-based therapies may serve as effective adjuncts to conventional treatment, particularly in the early or preventive stages of MetS. The review highlights the importance of standardized formulations, enhanced delivery systems, and well-controlled clinical trials to validate their efficacy and integrate them into evidence-based therapeutic protocols. These findings support the growing role of natural products in the holistic management of metabolic syndrome.

Authors

Institutions

Publication Details

Journal
Current Diabetes Reviews
Published
2026-07-01
DOI
https://doi.org/10.2174/0115733998431771260403053100
Primary Topic
Natural Antidiabetic Agents Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Herbal Medicine and Metabolic Syndrome: Phytochemicals Targeting the Molecular Causes of Insulin Resistance and Related Comorbidities

Hussein F. Sakr, Salma A. Elsamanoudy, Hajar Al-Rajaibi, Ayman Z. Elsamanoudy
Current Diabetes Reviews
Natural Antidiabetic Agents Studies
article

Herbal Medicine and Metabolic Syndrome: Phytochemicals Targeting the Molecular Causes of Insulin Resistance and Related Comorbidities

Hussein F. Sakr, Salma A. Elsamanoudy, Hajar Al-Rajaibi, Ayman Z. Elsamanoudy
article en

Abstract

Metabolic Syndrome (MetS) is a global health concern characterized by a cluster of interrelated metabolic abnormalities, including insulin resistance, central obesity, dyslipidemia, hypertension, and chronic low-grade inflammation. These factors significantly increase the risk of developing Type 2 Diabetes Mellitus (T2DM), Cardiovascular Disease (CVD), and other complications. In recent years, plant-derived natural products and herbal medicines have garnered increasing attention for their potential to modulate the underlying mechanisms of Metabolic Syndrome (MetS) safely and cost-effectively. This review explores the therapeutic role and molecular mechanisms of several key botanicals, including berberine, <i>Cinnamomum cassia</i> (Cinnamon), <i>Zingiber officinale</i> (ginger), <i>Trigonella foenum-graecum</i> (Fenugreek), <i>Nigella sativa</i> (black seed), <i>Curcuma longa</i> (Curcumin), <i>Artemisia dracunculus</i> (Russian tarragon), <i>Momordica charantia</i> (bitter melon), and <i>Vaccinium angustifolium</i> (lowbush blueberry). These agents exert multifaceted effects, including the activation of AMPK, enhancement of insulin receptor signaling, increased GLUT4 translocation, anti-inflammatory and antioxidant activities, and modulation of lipid metabolism and gut microbiota. While preclinical data strongly support their efficacy, human clinical trials have shown mixed results due to factors such as inconsistent formulations, poor bioavailability, and individual variability. Despite these challenges, the evidence suggests that plant-based therapies may serve as effective adjuncts to conventional treatment, particularly in the early or preventive stages of MetS. The review highlights the importance of standardized formulations, enhanced delivery systems, and well-controlled clinical trials to validate their efficacy and integrate them into evidence-based therapeutic protocols. These findings support the growing role of natural products in the holistic management of metabolic syndrome.

Current Diabetes ReviewsVol. 22
Mansoura University (EG), King Abdulaziz University (SA), Sultan Qaboos University (OM)
Openalex Percentile: Top 7%
Natural Antidiabetic Agents Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.